XRAY (STOCKS)
DENTSPLY SIRONA Inc.
$11.790000
+0.080000 (+0.68%)
Prev close: $11.710000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Daniel T. Scavilla
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,398.99M
- Employees
- 14,000
- P/E (TTM)
- -4.01
- P/B (TTM)
- 1.79
- Dividend Yield
- 532.45%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
12
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.27 | $0.28 | -0.0136 | -4.80% |
|
Sep 2025 (Q3)
|
$0.37 | $0.46 | -0.0870 | -19.04% |
|
Jun 2025 (Q2)
|
$0.52 | $0.51 | +0.0076 | +1.48% |
|
Mar 2025 (Q1)
|
$0.43 | $0.30 | +0.1342 | +45.37% |
Financial Statements
| Revenues | $3.68B |
| Benefits Costs and Expenses | $4.17B |
| Cost Of Revenue | $1.84B |
| Costs And Expenses | $4.17B |
| Gross Profit | $1.84B |
| Operating Expenses | $2.26B |
| Selling, General, and Administrative Expenses | $1.44B |
| Research and Development | $150.00M |
| Other Operating Expenses | $674.00M |
| Operating Income/Loss | -$422.00M |
| Income/Loss From Continuing Operations After Tax | -$598.00M |
| Income/Loss From Continuing Operations Before Tax | -$486.00M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | $112.00M |
| Income Tax Expense/Benefit, Current | $82.00M |
| Income Tax Expense/Benefit, Deferred | $30.00M |
| Net Income/Loss | -$598.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$598.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$598.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.00 |
| Diluted Earnings Per Share | -$3.00 |
| Basic Average Shares | 199,400,000 |
| Diluted Average Shares | 199,400,000 |
| Assets | $5.43B |
| Current Assets | $2.02B |
| Inventory | $642.00M |
| Prepaid Expenses | $140.00M |
| Other Current Assets | $1.24B |
| Noncurrent Assets | $3.41B |
| Intangible Assets | $974.00M |
| Other Non-current Assets | $2.43B |
| Liabilities | $4.09B |
| Current Liabilities | $1.34B |
| Accounts Payable | $300.00M |
| Wages | $171.00M |
| Other Current Liabilities | $872.00M |
| Noncurrent Liabilities | $2.75B |
| Long-term Debt | $2.28B |
| Other Non-current Liabilities | $470.00M |
| Equity | $1.34B |
| Equity Attributable To Noncontrolling Interest | $1.00M |
| Equity Attributable To Parent | $1.34B |
| Liabilities And Equity | $5.43B |
| Net Cash Flow From Operating Activities | $235.00M |
| Net Cash Flow From Operating Activities, Continuing | $235.00M |
| Net Cash Flow From Investing Activities | -$132.00M |
| Net Cash Flow From Investing Activities, Continuing | -$132.00M |
| Net Cash Flow From Financing Activities | -$80.00M |
| Net Cash Flow From Financing Activities, Continuing | -$80.00M |
| Exchange Gains/Losses | $31.00M |
| Net Cash Flow | $54.00M |
| Net Cash Flow, Continuing | $23.00M |
| Comprehensive Income/Loss | -$507.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$507.00M |
| Other Comprehensive Income/Loss | $91.00M |